Name: Latest research reports of Ajanta Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2679.2000 -15.40 (-0.57%)

NSE Apr 21, 2025 15:31 PM

28.81% Gain from 52W Low

Volume: 44,726

Ajanta Pharma Ltd.

30 Jan 2025

2679.20

-0.57%

India/Asia drive earnings

Buy: Ajanta Pharma Ltd.

Target

Motilal Oswal

Ajanta Pharma (AJP) delivered a marginally better-than-expected performance in 3QFY25. It has continued to outperform in the Domestic Formulation (DF) market during this quarter.

Ajanta Pharma Ltd. is trading above its 50 day SMA of 2611.9